Fig. 1: Neural network layout.

Final layouts of the ANN models for the analysis conducted using the changes from screening to baseline of the individual items of the MADRS and HAMD-17 clinical scales used as potential predictors of the response (resp = response to placebo) for the SEP360-029 study (A) and for the SEP380-201 study (B).